NEW YORK (GenomeWeb News) - Clinical Data said today that its Cogenics services business has installed a Radius Automation from Protedyne for use in qPCR and CLIA sequencing services.
Clinical Data's Cogenics unit develops GLP-validated research assays for genotyping, sequencing, qPCR and gene expression research. The group was demarcated as a distinct business unit last year when Clinical Data restructured its operations into three divisions.
Cogenics includes capabilities and infrastructure that Clinical Data picked up in its acquisitions of Genaissance, Lark, and Icoria.
Cogenics will use Protedyne’s robotic benchtop platform in its services business. Robert Bondaryk, Cogenics’ general manager, said the automated system will support Clinical Data’s Familion Long QT tests and new CLIA sequencing tests developed by its PGxHealth Division.
Financial terms of the sale were not disclosed.